Vaxcyte, Inc. PCVX Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s common stock, shares, outstanding?
- Vaxcyte, Inc. (PCVX) reported common stock, shares, outstanding of $144.31M in Q1 2026.
- How has Vaxcyte, Inc.'s common stock, shares, outstanding changed year-over-year?
- Vaxcyte, Inc.'s common stock, shares, outstanding increased by 11.9% year-over-year, from $128.94M to $144.31M.
- What is the long-term trend for Vaxcyte, Inc.'s common stock, shares, outstanding?
- Over 2 years (2023 to 2025), Vaxcyte, Inc.'s common stock, shares, outstanding has grown at a 17.2% compound annual growth rate (CAGR), from $95.36M to $131.06M.